Skip to main content

Advertisement

SpringerLink
Log in

How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rodriguez-Wallberg KA, Eloranta S, Krawiec K, Lissmats A, Bergh J, Liljegren A (2017) Safety of fertility preservation in breast cancer patients in a register-based matched cohort study. Breast Cancer Res Treat 1–9

  2. Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P et al (2017) 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med 377(19):1836–1846

    Article  PubMed  Google Scholar 

  3. Kim J, Turan V, Oktay K (2016) Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab 101(4):1364–1371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Breast Cancer Translational Research Laboratory, Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo, 121, 1000, Brussels, Belgium

    Matteo Lambertini

  2. CRO Aviano, Pordenone, Italy

    Caterina Fontanella

Authors
  1. Matteo Lambertini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caterina Fontanella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Lambertini.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest in relation to this article. Matteo Lambertini acknowledges the support from the European Society for Medical Oncology (ESMO) for a Translational Research Fellowship at the Institut Jules Bordet, Brussels, Belgium.

Ethical approval

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lambertini, M., Fontanella, C. How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?. Breast Cancer Res Treat 168, 773–774 (2018). https://doi.org/10.1007/s10549-017-4654-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4654-1

Search

Navigation